|
2A0256
|
6505-01-159-1763
|
Usp Dextrose Injection |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC00338-0035-06
|
6505-01-159-1763
|
Usp Dextrose Injection |
Baxter Healthcare Corp
|
|
Quote
|
|
DIANEAL 137
|
6505-01-159-2964
|
Peritoneal Dialysis Solution |
Baxter Healthcare Corp
|
|
Quote
|
|
5B5704
|
6505-01-159-2964
|
Peritoneal Dialysis Solution |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC00941-0383-04
|
6505-01-159-2964
|
Peritoneal Dialysis Solution |
Baxter Healthcare Corp
|
|
Quote
|
|
DIANEAL 137
|
6505-01-159-2965
|
Peritoneal Dialysis Solution |
Baxter Healthcare Corp
|
|
Quote
|
|
5B5354
|
6505-01-159-2965
|
Peritoneal Dialysis Solution |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC00941-0379-04
|
6505-01-159-2965
|
Peritoneal Dialysis Solution |
Baxter Healthcare Corp
|
|
Quote
|
|
POLY-VI-SOL-W/IRON
|
6505-01-159-3638
|
Multivitamin And Iron Oral Solut |
Mead Johnson & Company, Llc
|
|
Quote
|
|
NDC00087-0405-01
|
6505-01-159-3638
|
Multivitamin And Iron Oral Solut |
Mead Johnson & Company, Llc
|
|
Quote
|
|
TIGAN
|
6505-01-159-3647
|
Trimethobenzamide Hydrochloride |
King Pharmaceuticals Inc
|
|
Quote
|
|
NDC00029-4082-30
|
6505-01-159-3647
|
Trimethobenzamide Hydrochloride |
King Pharmaceuticals Inc
|
|
Quote
|
|
TIGAN CAPSULES
|
6505-01-159-3648
|
Trimethobenzamide Hydrochloride |
King Pharmaceuticals Inc
|
|
Quote
|
|
TIGAN
|
6505-01-159-3648
|
Trimethobenzamide Hydrochloride |
King Pharmaceuticals Inc
|
|
Quote
|
|
NDC00029-4083-32
|
6505-01-159-3648
|
Trimethobenzamide Hydrochloride |
King Pharmaceuticals Inc
|
|
Quote
|
|
5B5344
|
6505-01-159-3649
|
Peritoneal Dialysis Solution |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC00941-0377-04
|
6505-01-159-3649
|
Peritoneal Dialysis Solution |
Baxter Healthcare Corp
|
|
Quote
|
|
NDC53905-0281-10
|
6505-01-159-4570
|
Daunorubicin Hydrochloride For I |
Novartis Vaccines and Diagnostics,
|
|
Quote
|
|
NDC63323-0119-08
|
6505-01-159-4570
|
Daunorubicin Hydrochloride For I |
American Pharmaceutical Partners
|
|
Quote
|
|
NDC55390-0805-10
|
6505-01-159-4570
|
Daunorubicin Hydrochloride For I |
Mova Pharmaceutical Corp
|
|
Quote
|
|
NDC55390-0281-10
|
6505-01-159-4570
|
Daunorubicin Hydrochloride For I |
Falcon Pharmaceuticals Ltd
|
|
Quote
|
|
DELSYM SYRUP
|
6505-01-159-4786
|
Dextromethorphan Hydrobromide Sy |
Mcneil Consumer Products Co
|
|
Quote
|
|
28803
|
6505-01-159-4786
|
Dextromethorphan Hydrobromide Sy |
Mcneil Consumer Products Co
|
|
Quote
|
|
NDC00045-0288-03
|
6505-01-159-4786
|
Dextromethorphan Hydrobromide Sy |
Mcneil Consumer Products Co
|
|
Quote
|
|
CAMA ARTHRITIS PAIN RELIEVER
|
6505-01-159-6862
|
And Magnesia Tab Alumina Aspirin |
Sandoz Consumer Health Care Group
|
|
Quote
|
|
NDC00043-0104-51
|
6505-01-159-6862
|
And Magnesia Tab Alumina Aspirin |
Sandoz Consumer Health Care Group
|
|
Quote
|
|
OPHTHOCORT OINTMENT
|
6505-01-159-6863
|
Hydrocortisone A Chloramphenicol |
Parke-davis
|
|
Quote
|
|
NDC00071-3079-07
|
6505-01-159-6863
|
Hydrocortisone A Chloramphenicol |
Parke-davis
|
|
Quote
|
|
INTROPIN RAP-ADD
|
6505-01-159-6865
|
Dopamine Hydrochloride Injection |
Du Pont Critical Care Inc
|
|
Quote
|
|
NDC00186-0642-01
|
6505-01-159-6865
|
Dopamine Hydrochloride Injection |
Astra Pharmaceuticals Lp
|
|
Quote
|
|
NDC00097-0047-07
|
6505-01-159-6865
|
Dopamine Hydrochloride Injection |
Du Pont Critical Care Inc
|
|
Quote
|
|
ROBITUSSIN-PE
|
6505-01-159-6930
|
Pseudoephedrine Hydrochloride An |
Robins a H Co Inc
|
|
Quote
|
|
ROBITUSSIN-PE SYRUP
|
6505-01-159-6930
|
Pseudoephedrine Hydrochloride An |
Robins a H Co Inc
|
|
Quote
|
|
NDC00031-8695-12
|
6505-01-159-6930
|
Pseudoephedrine Hydrochloride An |
Robins a H Co Inc
|
|
Quote
|
|
CENTRAX
|
6505-01-159-6941
|
Usp Prazepam Capsules |
Parke-davis
|
|
Quote
|
|
CENTRAX CAPSULES
|
6505-01-159-6941
|
Usp Prazepam Capsules |
Parke-davis
|
|
Quote
|
|
NDC00071-0553-30
|
6505-01-159-6941
|
Usp Prazepam Capsules |
Parke-davis
|
|
Quote
|
|
ILETIN II
|
6505-01-159-6942
|
Usp Insulin Injection |
Eli Lilly and Company
|
|
Quote
|
|
CP-210S
|
6505-01-159-6942
|
Usp Insulin Injection |
Eli Lilly and Company
|
|
Quote
|
|
NDC00002-8212-01
|
6505-01-159-6942
|
Usp Insulin Injection |
Eli Lilly and Company
|
|
Quote
|
|
KAON CL-10
|
6505-01-159-7861
|
Potassium Chloride Tablets |
Erbamont Inc
|
|
Quote
|
|
NDC00013-3041-21
|
6505-01-159-7861
|
Potassium Chloride Tablets |
Erbamont Inc
|
|
Quote
|
|
NDC00024-0722-12
|
6505-01-159-9091
|
Usp Heparin Lock Flush Solution |
Sterling-winthrop Research Institute
|
|
Quote
|
|
COPPER TRACE METAL
|
6505-01-159-9243
|
Usp Cupric Chloride Injection |
Abbott Laboratories Inc.
|
|
Quote
|
|
NDC00074-4092-01
|
6505-01-159-9243
|
Usp Cupric Chloride Injection |
Abbott Laboratories Inc.
|
|
Quote
|
|
NDC00074-4092-01
|
6505-01-159-9243
|
Usp Cupric Chloride Injection |
Abbott Laboratories Inc
|
|
Quote
|
|
NDC00074-4092-01
|
6505-01-159-9243
|
Usp Cupric Chloride Injection |
Abbott Laboratories
|
|
Quote
|
|
QUIBRON-T/SR
|
6505-01-159-9250
|
Theophylline Extended-release Ta |
Mead Johnson & Company, Llc
|
|
Quote
|
|
NDC61570-0019-01
|
6505-01-159-9250
|
Theophylline Extended-release Ta |
Monarch Pharmaceuticals Inc
|
|
Quote
|
|
NDC00087-0519-41
|
6505-01-159-9250
|
Theophylline Extended-release Ta |
Bristol-myers Squibb Co
|
|
Quote
|
|
QUIBRON-T
|
6505-01-159-9251
|
Usp Theophylline Tablets |
Mead Johnson & Company, Llc
|
|
Quote
|
|
QUIBRON-T TABLETS
|
6505-01-159-9251
|
Usp Theophylline Tablets |
Mead Johnson & Company, Llc
|
|
Quote
|
|
NDC61570-0020-01
|
6505-01-159-9251
|
Usp Theophylline Tablets |
Monarch Pharmaceuticals Inc
|
|
Quote
|
|
NDC54092-0069-01
|
6505-01-159-9251
|
Usp Theophylline Tablets |
Mead Johnson & Company, Llc
|
|
Quote
|
|
NDC00087-0512-41
|
6505-01-159-9251
|
Usp Theophylline Tablets |
Mead Johnson & Company, Llc
|
|
Quote
|
|
RITALIN-SR
|
6505-01-160-4201
|
Methylphenidate Hydrochloride Ex |
Ciba-geigy Corp
|
|
Quote
|
|
RITALIN-SR TABLETS
|
6505-01-160-4201
|
Methylphenidate Hydrochloride Ex |
Ciba-geigy Corp
|
|
Quote
|
|
NDC00083-0016-30
|
6505-01-160-4201
|
Methylphenidate Hydrochloride Ex |
Ciba-geigy Corp
|
|
Quote
|
|
5015
|
6505-01-160-4986
|
Thiopental Sodium For Injection |
International Medication Systems,
|
|
Quote
|
|
NDC00548-5015-00
|
6505-01-160-4986
|
Thiopental Sodium For Injection |
International Medication Systems,
|
|
Quote
|
|
CENTRAX CAPSULES
|
6505-01-160-6778
|
Usp Prazepam Capsules |
Parke-davis
|
|
Quote
|
|
NDC00071-0552-30
|
6505-01-160-6778
|
Usp Prazepam Capsules |
Parke-davis
|
|
Quote
|
|
CENTRAX CAPSULES
|
6505-01-160-6778
|
Usp Prazepam Capsules |
Parke-davis
|
|
Quote
|
|
NDC00071-0552-30
|
6505-01-160-6778
|
Usp Prazepam Capsules |
Parke-davis
|
|
Quote
|
|
CENTRAX CAPSULES
|
6505-01-160-6778
|
Usp Prazepam Capsules |
Parke-davis
|
|
Quote
|
|
NDC00071-0552-30
|
6505-01-160-6778
|
Usp Prazepam Capsules |
Parke-davis
|
|
Quote
|
|
ZANTAC TABLETS
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Glaxo Wellcome Inc
|
|
Quote
|
|
NDC00173-0344-42
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Glaxo Wellcome Inc
|
|
Quote
|
|
NDC55289-0319-60
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Pd-rx Pharmaceuticals, Inc.
|
|
Quote
|
|
NDC53746-0253-60
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Amneal Pharmaceuticals of New York,
|
|
Quote
|
|
1525534
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Association Pharmaceutique Belge
|
|
Quote
|
|
ZANTAC 150 COMP 56 X 150MG
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Glaxosmithkline Pharmaceuticals Sa
|
|
Quote
|
|
RANITIDINE EG 150MG X 56 COMP
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Eurogenerics S.a.
|
|
Quote
|
|
1525-534
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Sandoz
|
|
Quote
|
|
RANITIDINE SANDOZ 60X150MG
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Sandoz
|
|
Quote
|
|
DOCRANITI 150MG 56 COMP
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Docpharma N.v.
|
|
Quote
|
|
1487016
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Association Pharmaceutique Belge
|
|
Quote
|
|
ZANTAC TABLETS
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Glaxo Wellcome Inc
|
|
Quote
|
|
NDC55289-0319-60
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Pd-rx Pharmaceuticals, Inc.
|
|
Quote
|
|
NDC53746-0253-60
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Amneal Pharmaceuticals of New York,
|
|
Quote
|
|
ZANTAC 150 COMP 56 X 150MG
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Glaxosmithkline Pharmaceuticals Sa
|
|
Quote
|
|
1525-534
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Sandoz
|
|
Quote
|
|
RANITIDINE SANDOZ 60X150MG
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Sandoz
|
|
Quote
|
|
RANITIDINE EG 150MG X 56 COMP
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Eurogenerics S.a.
|
|
Quote
|
|
DOCRANITI 150MG 56 COMP
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Docpharma N.v.
|
|
Quote
|
|
NDC00173-0344-42
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Glaxo Wellcome Inc
|
|
Quote
|
|
1487016
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Association Pharmaceutique Belge
|
|
Quote
|
|
1525534
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Association Pharmaceutique Belge
|
|
Quote
|
|
ZANTAC TABLETS
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Glaxo Wellcome Inc
|
|
Quote
|
|
NDC55289-0319-60
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Pd-rx Pharmaceuticals, Inc.
|
|
Quote
|
|
NDC53746-0253-60
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Amneal Pharmaceuticals of New York,
|
|
Quote
|
|
ZANTAC 150 COMP 56 X 150MG
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Glaxosmithkline Pharmaceuticals Sa
|
|
Quote
|
|
RANITIDINE SANDOZ 60X150MG
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Sandoz
|
|
Quote
|
|
RANITIDINE EG 150MG X 56 COMP
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Eurogenerics S.a.
|
|
Quote
|
|
1525-534
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Sandoz
|
|
Quote
|
|
DOCRANITI 150MG 56 COMP
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Docpharma N.v.
|
|
Quote
|
|
NDC00173-0344-42
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Glaxo Wellcome Inc
|
|
Quote
|
|
1525534
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Association Pharmaceutique Belge
|
|
Quote
|
|
1487016
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Association Pharmaceutique Belge
|
|
Quote
|
|
ZANTAC TABLETS
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Glaxo Wellcome Inc
|
|
Quote
|
|
NDC55289-0319-60
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Pd-rx Pharmaceuticals, Inc.
|
|
Quote
|
|
NDC53746-0253-60
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Amneal Pharmaceuticals of New York,
|
|
Quote
|
|
ZANTAC 150 COMP 56 X 150MG
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Glaxosmithkline Pharmaceuticals Sa
|
|
Quote
|
|
RANITIDINE EG 150MG X 56 COMP
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Eurogenerics S.a.
|
|
Quote
|
|
1525-534
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Sandoz
|
|
Quote
|
|
DOCRANITI 150MG 56 COMP
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Docpharma N.v.
|
|
Quote
|
|
RANITIDINE SANDOZ 60X150MG
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Sandoz
|
|
Quote
|
|
NDC00173-0344-42
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Glaxo Wellcome Inc
|
|
Quote
|
|
1487016
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Association Pharmaceutique Belge
|
|
Quote
|
|
1525534
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Association Pharmaceutique Belge
|
|
Quote
|
|
ZANTAC TABLETS
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Glaxo Wellcome Inc
|
|
Quote
|
|
NDC55289-0319-60
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Pd-rx Pharmaceuticals, Inc.
|
|
Quote
|
|
NDC53746-0253-60
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Amneal Pharmaceuticals of New York,
|
|
Quote
|
|
ZANTAC 150 COMP 56 X 150MG
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Glaxosmithkline Pharmaceuticals Sa
|
|
Quote
|
|
1525-534
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Sandoz
|
|
Quote
|
|
RANITIDINE SANDOZ 60X150MG
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Sandoz
|
|
Quote
|
|
RANITIDINE EG 150MG X 56 COMP
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Eurogenerics S.a.
|
|
Quote
|
|
DOCRANITI 150MG 56 COMP
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Docpharma N.v.
|
|
Quote
|
|
NDC00173-0344-42
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Glaxo Wellcome Inc
|
|
Quote
|
|
1487016
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Association Pharmaceutique Belge
|
|
Quote
|
|
1525534
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Association Pharmaceutique Belge
|
|
Quote
|
|
ZANTAC TABLETS
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Glaxo Wellcome Inc
|
|
Quote
|
|
NDC55289-0319-60
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Pd-rx Pharmaceuticals, Inc.
|
|
Quote
|
|
NDC53746-0253-60
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Amneal Pharmaceuticals of New York,
|
|
Quote
|
|
ZANTAC 150 COMP 56 X 150MG
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Glaxosmithkline Pharmaceuticals Sa
|
|
Quote
|
|
RANITIDINE SANDOZ 60X150MG
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Sandoz
|
|
Quote
|
|
RANITIDINE EG 150MG X 56 COMP
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Eurogenerics S.a.
|
|
Quote
|
|
1525-534
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Sandoz
|
|
Quote
|
|
DOCRANITI 150MG 56 COMP
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Docpharma N.v.
|
|
Quote
|
|
NDC00173-0344-42
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Glaxo Wellcome Inc
|
|
Quote
|
|
1525534
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Association Pharmaceutique Belge
|
|
Quote
|
|
1487016
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Association Pharmaceutique Belge
|
|
Quote
|
|
ZANTAC TABLETS
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Glaxo Wellcome Inc
|
|
Quote
|
|
NDC55289-0319-60
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Pd-rx Pharmaceuticals, Inc.
|
|
Quote
|
|
NDC53746-0253-60
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Amneal Pharmaceuticals of New York,
|
|
Quote
|
|
ZANTAC 150 COMP 56 X 150MG
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Glaxosmithkline Pharmaceuticals Sa
|
|
Quote
|
|
RANITIDINE EG 150MG X 56 COMP
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Eurogenerics S.a.
|
|
Quote
|
|
1525-534
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Sandoz
|
|
Quote
|
|
DOCRANITI 150MG 56 COMP
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Docpharma N.v.
|
|
Quote
|
|
RANITIDINE SANDOZ 60X150MG
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Sandoz
|
|
Quote
|
|
NDC00173-0344-42
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Glaxo Wellcome Inc
|
|
Quote
|
|
1487016
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Association Pharmaceutique Belge
|
|
Quote
|
|
1525534
|
6505-01-160-7702
|
Usp Ranitidine Tablets |
Association Pharmaceutique Belge
|
|
Quote
|
|
ARTANE
|
6505-01-160-7721
|
Trihexyphenidyl Hydrochloride Ex |
American Cyanamid Co
|
|
Quote
|
|
NDC00005-4438-32
|
6505-01-160-7721
|
Trihexyphenidyl Hydrochloride Ex |
American Cyanamid Co
|
|
Quote
|
|
NDC00005-4438-32
|
6505-01-160-7721
|
Trihexyphenidyl Hydrochloride Ex |
American Cyanamid Co
|
|
Quote
|
|
ARTANE
|
6505-01-160-7721
|
Trihexyphenidyl Hydrochloride Ex |
American Cyanamid Co
|
|
Quote
|
|
NDC00005-4438-32
|
6505-01-160-7721
|
Trihexyphenidyl Hydrochloride Ex |
American Cyanamid Co
|
|
Quote
|
|
ARTANE
|
6505-01-160-7721
|
Trihexyphenidyl Hydrochloride Ex |
American Cyanamid Co
|
|
Quote
|
|
NDC00005-4438-32
|
6505-01-160-7721
|
Trihexyphenidyl Hydrochloride Ex |
American Cyanamid Co
|
|
Quote
|
|
ARTANE
|
6505-01-160-7721
|
Trihexyphenidyl Hydrochloride Ex |
American Cyanamid Co
|
|
Quote
|
|
NDC00005-4438-32
|
6505-01-160-7721
|
Trihexyphenidyl Hydrochloride Ex |
American Cyanamid Co
|
|
Quote
|
|
ARTANE
|
6505-01-160-7721
|
Trihexyphenidyl Hydrochloride Ex |
American Cyanamid Co
|
|
Quote
|
|
NDC00005-4438-32
|
6505-01-160-7721
|
Trihexyphenidyl Hydrochloride Ex |
American Cyanamid Co
|
|
Quote
|
|
ARTANE
|
6505-01-160-7721
|
Trihexyphenidyl Hydrochloride Ex |
American Cyanamid Co
|
|
Quote
|
|
NDC00005-4438-32
|
6505-01-160-7721
|
Trihexyphenidyl Hydrochloride Ex |
American Cyanamid Co
|
|
Quote
|
|
ARTANE
|
6505-01-160-7721
|
Trihexyphenidyl Hydrochloride Ex |
American Cyanamid Co
|
|
Quote
|
